Edwards Lifesciences (NYSE: EW) announced that in consultation with trial investigators, the company has voluntarily implemented a temporary pause on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE